• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Cantel Medical and Censis Technologies Enter into Partnership to Develop Differentiated Endoscope Reprocessing Software Solution

    12/7/20 11:00:00 AM ET
    $CMD
    Medical/Dental Instruments
    Health Care
    Get the next $CMD alert in real time by email

    LITTLE FALLS, N.J., Dec. 7, 2020 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE:CMD) and Censis Technologies announced today a new long-term partnership to combine Cantel's leading infection prevention endoscope reprocessing workflow portfolio with the surgical asset management and instrument tracking solutions from Censis.

    The new enhanced, co-branded software solution will combine the CANEXIS™ Integrated Workflow Solution for Endoscopy from Cantel with Censis' CensiTrac® surgical asset management software to create the leading instrument reprocessing and scope tracking software available to the market. Leveraging Censis' strengths in software development, cloud-based technology, and professional services and support with the leading position in endoscope reprocessing and infection prevention from Cantel, the combined solution will support endoscopy customers with best-in-class quality management tools, providing peace of mind and confidence that their facility is executing best practices to support patient safety and infection prevention.

    This enhanced integrated workflow solution is a key tool in the fight to avoid the spread of infection, while helping to protect patients and reducing the economic burden on facilities, while also supporting improved efficiency and understanding of the use of critical medical devices in healthcare facilities. In today's environment, efficiency and process consistency are increasingly critical to the day-to-day and long-term success of infection prevention, and this software application is an important resource for helping to ensure a consistent repeatable standard of care and process at each facility.

    Healthcare associated infections (HAIs) are a complex and persistent issue in healthcare facilities. Each year, approximately 1.7 million HAIs occur, and outbreaks also pose a severe economic burden to the health system, with the total direct, indirect, and nonmedical social costs of HAIs to hospitals ranging from US$96 billion to $147 billion.1

    "We are thrilled to be partnering with Censis on this critical endeavor," said Michael Spicer, President, Medical Business Unit at Cantel. "At Cantel, we strive to ensure our Complete Circle of Protection includes best-in-class offerings for our customers and patients, and by partnering with Censis, we are taking the next step toward providing greater efficiency, protection, and analytics to allow our customers to maximize their practice workflow while providing solutions designed to improve the safety and protection of their patients."

    Randy Smith, CEO, Censis Technologies said, "The relationship with Cantel will expand Censis' leadership in surgical asset management and tracking solutions by further introducing innovative SaaS-based technology for the reprocessing of endoscopes. We are excited that the combined efforts of these two organizations will provide our customers opportunities to improve patient safety, workflow optimization and analytics."

    Within the United States, users of the current CANEXIS™ Software can look forward to robust coverage, including implementation, upgrades, and technical support, as their service is enhanced through the co-brand partnership.

    About Cantel Medical:
    Cantel Medical is a leading global company dedicated to delivering innovative infection prevention products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives. Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, instruments and instrument reprocessing workflow systems serving the dental industry, dialysate concentrates, hollow fiber membrane filtration and separation products. Additionally, we provide technical service for our products.

    For further information, visit www.cantelmedical.com.

    About Censis Technologies
    Censis Technologies, based in Franklin, Tennessee, is the leader in surgical instrument and asset management software. Censis offers a range of solutions, including CensiTrac, which is a highly advanced, web-based software system focused on maximizing OR throughput and regulatory compliance. Censis Technologies' software is deployed in over 1000 hospitals in the United States, Canada, and Australia.

    For more information, visit www.censis.com.

    1 Beckershospitalreview.com. 2015. How HAIs Lead to Direct, Indirect and Unintended Hospital Costs. [online] Available at: https://www.beckershospitalreview.com/quality/how-hais-lead-to-direct-indirect-and-unintended-hospital-costs.html

    SOURCE Cantel Medical Corp.

    Related Links

    http://www.cantelmedical.com

    Get the next $CMD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CMD

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CMD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Cantel Medical Corp.

    4 - CANTEL MEDICAL CORP (0000019446) (Issuer)

    6/2/21 5:27:45 PM ET
    $CMD
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Cantel Medical Corp.

    4 - CANTEL MEDICAL CORP (0000019446) (Issuer)

    6/2/21 5:28:15 PM ET
    $CMD
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Cantel Medical Corp.

    4 - CANTEL MEDICAL CORP (0000019446) (Issuer)

    6/2/21 5:27:18 PM ET
    $CMD
    Medical/Dental Instruments
    Health Care

    $CMD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Sanitizing Agents Market Poised for over 7.8% Growth by 2029, Growing by Increasing Investment in The Development of Eco-Friendly Acid-Based Chemicals: States by Exactitude Consultancy

    The Sanitizing Agents Market size is expected to reach 32.34 USD billion by 2029; Sanitizing Agents are a necessary sanitary product for maintaining hygiene and cleanliness in homes and environments PUNE, India, Sept. 21, 2022 /PRNewswire/ -- Sanitation has become an important aspect of the major industrial processes and commercial sectors. Sanitizing agents are being used more frequently to maintain a level of sanitation. The growing awareness of the importance of food product quality is a major reason why demand for sanitizing agents is expected to rise due to their efficiency and cost-effectiveness. Access PDF Sample Report (Including Graphs, Charts & Figures) @ https://exactitudeconsulta

    9/21/22 11:30:00 AM ET
    $CMD
    Medical/Dental Instruments
    Health Care

    Crocs Set to Join S&P MidCap 400 and Organogenesis to Join S&P SmallCap 600

    NEW YORK, May 26, 2021 /PRNewswire/ -- S&P SmallCap 600 constituent Crocs Inc. (NASD:CROX) will replace Cantel Medical Corp. (NYSE:CMD) in the S&P MidCap 400, and Organogenesis Holdings Inc. (NASD: ORGO) will replace Crocs in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, June 2, 2021. STERIS plc (NYSE:STE) is acquiring Cantel Medical in a deal expected to be completed soon pending final closing conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector June 2, 2021 S&P MidCap 400 Addition Crocs CROX Consumer Discretionary S&P M

    5/26/21 5:50:00 PM ET
    $STE
    $CMD
    $SPGI
    Industrial Specialties
    Health Care
    Medical/Dental Instruments
    Finance: Consumer Services

    Mar Cor Launches Its Newest and Most Advanced Portable Reverse Osmosis Water System

    The EON™ Portable Dialysis Water System produces high-quality medical water for acute and home hemodialysis use Mar Cor Purification, Inc., a Cantel Medical Corp. (NYSE:CMD) business, announces the launch of the EON™ Portable Dialysis Water System. The portable water purification device uses reverse osmosis (RO) to remove organic and inorganic substances and microbial contaminants from water that feeds into hemodialysis machines to treat hemodialysis patients or related therapies. The water system quickly delivers and efficiently produces medical-grade water for single-patient hemodialysis treatments in hospitals, clinics, skilled nursing centers, and home environments. This press release

    5/6/21 11:04:00 AM ET
    $CMD
    Medical/Dental Instruments
    Health Care

    $CMD
    SEC Filings

    View All

    SEC Form SC TO-I/A filed by Cantel Medical Corp. (Amendment)

    SC TO-I/A - CANTEL MEDICAL LLC (0000019446) (Subject)

    7/2/21 4:06:30 PM ET
    $CMD
    Medical/Dental Instruments
    Health Care

    SEC Form SC TO-I/A filed by Cantel Medical Corp. (Amendment)

    SC TO-I/A - CANTEL MEDICAL LLC (0000019446) (Subject)

    6/29/21 4:16:59 PM ET
    $CMD
    Medical/Dental Instruments
    Health Care

    SEC Form 15-12B filed by Cantel Medical Corp.

    15-12B - CANTEL MEDICAL LLC (0000019446) (Filer)

    6/14/21 4:06:30 PM ET
    $CMD
    Medical/Dental Instruments
    Health Care

    $CMD
    Leadership Updates

    Live Leadership Updates

    View All

    Cantel Announces Senior Leadership Promotions in Dental

    LITTLE FALLS, N.J., Dec. 3, 2020 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE:CMD) announced today the appointment of Andy Xilas to President, Cantel Dental effective January 1, 2021. He will be taking over for Ken Serota, who will be stepping down as President effective December 31, 2020. In addition, Jennifer Naylor has been appointed to the newly created role of Senior Vice President, Infection Prevention and Control Strategy and Education for Cantel. Mr. Xilas and Ms. Naylor both joined Cantel in 2019, as part of Cantel's acquisition of Hu-Friedy and will sit on the Company's Executive Leadership Team. Mr. Xilas has held various positions at Hu-Friedy with increasing responsibility over

    12/3/20 9:00:00 AM ET
    $CMD
    Medical/Dental Instruments
    Health Care

    $CMD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Cantel Medical Corp.

    SC 13G - CANTEL MEDICAL LLC (0000019446) (Subject)

    6/10/21 4:11:25 PM ET
    $CMD
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Cantel Medical Corp. (Amendment)

    SC 13G/A - CANTEL MEDICAL CORP (0000019446) (Subject)

    5/10/21 12:31:25 PM ET
    $CMD
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed

    SC 13G/A - CANTEL MEDICAL CORP (0000019446) (Subject)

    3/10/21 4:38:59 PM ET
    $CMD
    Medical/Dental Instruments
    Health Care